CERN - CERN STOCK NEWS

Cerner Corporation (Nasdaq: CERN) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 10:00 a.m. EST. The event will feature key executives, including Chairman and CEO Brent Shafer and President Don Trigg, discussing Cerner's recent developments and offering forward-looking insights into business and financial matters. The presentation will be accessible live and archived on Cerner’s website in the Investor Relations section. Cerner is recognized for its innovative health technologies used in over 27,500 provider facilities globally.

Cerner Corporation (NASDAQ: CERN) announced its acquisition of Kantar Health for $375 million in cash, aimed at enhancing data analytics and clinical research within life sciences. This strategic move seeks to improve the efficacy and safety of clinical research, leveraging Kantar's expertise and real-world data. The acquisition is expected to close in the first half of 2021, pending regulatory approval. Cerner's Learning Health Network will benefit from this integration, allowing more direct collaborations with life sciences companies on funded research studies.

Cerner Corporation (Nasdaq: CERN) has announced a cash dividend of $0.22 per share, representing a 22% increase from the previous $0.18 dividend. The dividend will be payable on January 12, 2021, to shareholders of record by December 28, 2020. Cerner plans to continue regular quarterly dividends, although future amounts will depend on financial performance and Board approval.

Cerner Corporation (NASDAQ: CERN) has partnered with Xealth to enhance digital innovation in health care. This collaboration will provide health systems with centralized digital ordering and monitoring capabilities, allowing clinicians to prescribe digital therapeutics and other tools for chronic disease management, behavioral health, and telehealth services. Banner Health is among the first clients to implement these capabilities, aimed at improving patient engagement and clinical outcomes. The integration supports efficiency and meets the growing demand for remote monitoring.

Cerner Corporation (NASDAQ: CERN) has announced a strategic investment in Elligo Health Research, focusing on enhancing access to clinical trials through community-based healthcare practices. This partnership aims to expedite clinical research timelines and reduce costs associated with bringing therapies to market. Currently, the drug development process takes over 17 years and costs approximately $2.5 billion. Cerner's Learning Health Network now includes 51 health systems, driven by a shared mission with Elligo to overcome recruitment and logistical barriers in clinical trials.

Cerner Corporation (NASDAQ: CERN) has expanded its Board of Directors to 11 members, appointing Major General Elder Granger, M.D. (ret.) effective November 16, 2020. Dr. Granger, a seasoned leader in healthcare and military sectors, will enhance Cerner's governance with his extensive experience, particularly in commercial and federal health sectors. He will hold a newly created Class II Director seat and is set for re-election in the 2021 annual shareholder meeting. This appointment underscores Cerner's commitment to robust leadership in navigating complex healthcare environments.

Cerner Corporation (Nasdaq: CERN) announced new communication capabilities to enhance patient engagement and streamline clinician workflows. This collaboration with WELL Health Inc. integrates into Cerner's patient portal, moving interactions from email to text messaging. The initiative aims to improve communication efficiency, reduce administrative burdens, and provide personalized care experiences. Potential benefits include improved patient satisfaction, retention, and reduced time spent on scheduling and billing. Cerner's HealtheLife platform will automate critical health communications and support timely patient interactions.

Cerner Corporation (Nasdaq: CERN) announced its third quarter 2020 financial results on October 28, 2020. The report highlighted the departure of CFO Marc Naughton, expected in 2021, during which he will assist in the transition of responsibilities. An earnings conference call is scheduled for the same day at 3:30 p.m. CT to discuss the results and future outlook. The earnings release and further details can be accessed on Cerner’s Investor Relations website.

Cerner Corp (Nasdaq: CERN) successfully launched a modern electronic health record (EHR) at the Mann-Grandstaff VA Medical Center, marking a historic first for three federal departments—VA, DOD, and DHS—working together. This initiative benefits 18 million service members and veterans, promising improved health information exchange. The EHR is part of a broader modernization effort, enhancing healthcare delivery and interoperability across agencies. Notable achievements since 2019 include significant health data migrations and the deployment of Cerner's Centralized Scheduling Solution.